Patent · US Active

Optogenetic control of endothelial cells

US10149986B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 26, 2017
Grant dateDec 11, 2018
Priority date
Expiry dateJun 26, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features methods for regulating vascular properties by controlling the membrane properties of endothelial cells using optogenetics and light. The invention features methods to transport therapeutics across the vascular barrier into tissues such as the brain and the lung, with high spatial and temporal precision, and for controlling vascular properties such as vascular tone, arterial diameter, and vascular growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.